Commitments and Contingencies - Additional Information (Detail) - USD ($)		1 Months Ended	3 Months Ended
	Jun. 15, 2022	Aug. 31, 2022	Jun. 30, 2022	Sep. 30, 2022	Mar. 31, 2022	Sep. 16, 2021	Jul. 31, 2021
Commitments And Contingencies Disclosure [Line Items]
Percentage of common stock filed a lawsuit	5.00%
Legal and Other Expenses
Commitments And Contingencies Disclosure [Line Items]
Litigation amount		$ 400,000
A G C Biologics Inc | Service Agreements
Commitments And Contingencies Disclosure [Line Items]
Remaining obligations				$ 0
A G C Biologics Inc | Marzeptacog Alfa Activated And Dalcinonacog Alfa | Service Agreements
Commitments And Contingencies Disclosure [Line Items]
Cost of Manufacturing Services					$ 700,000
Dalcinonacog Alfa | Service Agreements
Commitments And Contingencies Disclosure [Line Items]
Remaining obligations				$ 0
Clinical trial services cost incurred on agreement termination			$ 800,000
Dalcinonacog Alfa | Service Agreements | Maximum
Commitments And Contingencies Disclosure [Line Items]
Cost of services as per agreement							$ 6,500,000
Catalent Indiana, LLC. | Dalcinonacog alfa.
Commitments And Contingencies Disclosure [Line Items]
Firm work order supporting clinical trials						$ 300,000